Cisplatin and etoposide combination therapy for primary glial tumors: Preliminary results

No abstract is available for this paper.

• Publication year

  1991

• Venue

  The Italian journal of neurological sciences (Testo stampato)

• Publication date

  1991-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/BF02337611PMID 1849504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemotherapy for Malignant Gliomas

  2014cited by this paper
• Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors

  2004cited by this paper
• In vitro chemosensitivity of brain tumors to cisplatin and its analogues, iproplatin and carboplatin

  2004cited by this paper
• A phase II study of cisplatin therapy in recurrent childhood brain tumors

  1989cited by this paper
• Therapy of Malignant Brain Tumors, Ed. by Kurt Jellinger, Springer-Verlag Wien, New York 1987(らいぶらりい)

  1989cited by this paper
• Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study.

  1989cited by this paper
• Chemotherapy for malignant gliomas.

  1988cited by this paper
• X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines.

  1988cited by this paper
• Results of Chemotherapy of Malignant Brain Tumors in Adults

  1987cited by this paper
• New drugs and new delivery techniques.

  1985cited by this paper
• Etoposide prior to cis-diamminedichloroplatinum in combination chemotherapy: in vitro and in vivo studies.

  1985cited by this paper
• Misonidazole combined with hyperfractionation in the management of malignant glioma.

  1984cited by this paper
• Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

  1984cited by this paper
• A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.

  1983cited by this paper
• Superfractionation in glioblastoma multiforme--results of a phase II study.

  1982cited by this paper
• Super fractionation in glioblastoma multiforme-results of a phase II study

  1982cited by this paper
• Cisplatin therapy in recurrent childhood brain tumors.

  1982cited by this paper
• Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

  1982cited by this paper
• Synergism between BCNU and irradiation in the treatment of anaplastic gliomas. An in vivo study using the avian sarcoma virus-induced glioma model.

  1979cited by this paper
• Cisplatin (cis-diamminedichloroplatinum II).

  1979cited by this paper
• A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.

  1979cited by this paper
• Reduction in size of a pituitary tumor by bromocriptine therapy.

  1979cited by this paper
• The role of cis-platinum in solid-tumor therapy.

  1979cited by this paper
• Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

  1978cited by this paper
• Inversion of the cerebral mantle as a complication of ventricular shunting. Case report.

  1978cited by this paper

• No citing papers are available for this paper.